Edition:
United States

Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

5,342JPY
10:38pm EST
Change (% chg)

¥5 (+0.09%)
Prev Close
¥5,337
Open
¥5,345
Day's High
¥5,358
Day's Low
¥5,311
Volume
898,500
Avg. Vol
2,294,196
52-wk High
¥5,587
52-wk Low
¥4,098

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 3.71 March 23 Feb 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 1 1 1
(2) OUTPERFORM 2 1 2 2
(3) HOLD 7 7 9 9
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 1 1 0
No Opinion 0 0 0 0
Mean Rating 2.45 2.90 2.85 2.67

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-17 1 418,200.00 418,200.00 418,200.00 --
Quarter Ending Sep-17 1 437,900.00 437,900.00 437,900.00 --
Year Ending Mar-17 12 1,720,020.00 1,753,100.00 1,690,600.00 1,857,200.00
Year Ending Mar-18 12 1,750,250.00 1,835,920.00 1,648,860.00 1,899,660.00
Earnings (per share)
Quarter Ending Jun-17 1 3.71 3.71 3.71 --
Quarter Ending Sep-17 1 8.57 8.57 8.57 --
Year Ending Mar-17 13 132.58 201.19 110.54 148.28
Year Ending Mar-18 13 142.85 225.22 78.64 160.65
LT Growth Rate (%) 2 15.38 19.26 11.50 14.19

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-16 449,358.00 465,045.00 15,686.66 3.49
Quarter Ending Sep-16 425,736.00 416,796.00 8,940.34 2.10
Quarter Ending Jun-16 413,109.00 434,005.00 20,896.25 5.06
Quarter Ending Mar-16 435,836.00 414,121.00 21,714.75 4.98
Quarter Ending Dec-15 478,700.00 489,208.00 10,508.00 2.20

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-17 418,200.00 418,200.00 -- -- --
Quarter Ending Sep-17 437,900.00 437,900.00 -- -- --
Year Ending Mar-17 1,720,020.00 1,723,460.00 1,720,420.00 1,709,050.00 1,857,200.00
Year Ending Mar-18 1,750,250.00 1,758,330.00 1,745,290.00 1,727,310.00 1,899,660.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-17 0 0 -- --
Quarter Ending Sep-17 0 0 -- --
Year Ending Mar-17 0 1 2 2
Year Ending Mar-18 0 1 3 1
Earnings

More From Around the Web